Literature DB >> 22149961

Dietary whole glucan particles do not affect antibody or cell-mediated immune responses to influenza virus vaccination in mice.

Brandt D Pence1, Shelly N Hester, Sharon M Donovan, Jeffrey A Woods.   

Abstract

Influenza virus is a serious health concern. β-glucans derived from plants, bacteria, and fungi have been shown to potentiate immune system responses including those elicited by vaccination. However, in these studies β-glucan was administered as an adjuvant in the vaccine preparation. We hypothesized that addition of a commercially available whole glucan particle supplement to the diet would improve immune response to primary and secondary influenza vaccination in mice. β-glucan was added to pelleted diet and fed to mice at concentrations designed to deliver 0 (control), 1.8 or 90 mg·kg(-1)·day(-1) to each mouse. Influenza vaccine was given intramuscularly in the left hindlimb and primary and secondary responses were assessed. Supplementation with β-glucan was not effective in boosting immune responses to the vaccine, either in the primary or secondary vaccination experiments. Surprisingly, addition of particulate β-glucan to the vaccine itself also failed to elicit a greater antibody response. These observations suggest that this particular form of β-glucan is ineffective in boosting immune response to intramuscular influenza vaccination. Further study is warranted to determine if the use of different mouse models, different vaccine delivery systems, or β-glucans purified from different strains of bacteria, fungi, or plants could improve outcomes using this or similar protocols.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22149961     DOI: 10.3109/08820139.2011.628732

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  2 in total

1.  Intestinal and systemic immune development and response to vaccination are unaffected by dietary (1,3/1,6)-β-D-glucan supplementation in neonatal piglets.

Authors:  Shelly N Hester; Sarah S Comstock; Shannon C Thorum; Marcia H Monaco; Brandt D Pence; Jeffrey A Woods; Sharon M Donovan
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

2.  Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.

Authors:  Xianliang Ji; Zhiguang Ren; Na Xu; Lingnan Meng; Zhijun Yu; Na Feng; Xiaoyu Sang; Shengnan Li; Yuanguo Li; Tiecheng Wang; Yongkun Zhao; Hualei Wang; Xuexing Zheng; Hongli Jin; Nan Li; Songtao Yang; Jinshan Cao; Wensen Liu; Yuwei Gao; Xianzhu Xia
Journal:  Viruses       Date:  2016-04-21       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.